Sunshine Biopharma's market cap is currently $6.69M. The company's EPS TTM is $-155.585; its P/E ratio is ―; Sunshine Biopharma is scheduled to report earnings on April 8, 2025, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 24.09M	$ 4.35M	$ 228.43K	$ 71.41K	$ 21.12K
Gross Profit	$ 8.34M	$ 1.70M	$ 110.60K	$ 45.56K	$ 10.07K
Operating Income	$ -4.79M	$ -8.67M	$ -2.44M	$ -576.87K	$ -641.64K
EBITDA	$ -3.82M	$ -26.45M	$ -12.09M	$ -2.60M	$ -948.38K
Net Income	$ -4.51M	$ -26.74M	$ -12.77M	$ -897.68K	$ -1.46M
Balance Sheet
Cash & Short-Term Investments	$ 16.29M	$ 21.83M	$ 2.05M	$ 989.89K	$ 40.50K
Total Assets	$ 27.35M	$ 29.24M	$ 2.20M	$ 1.05M	$ 98.14K
Total Debt	$ 657.71K	$ 4.27M	$ 1.90M	$ 1.91M	$ 715.57K
Net Debt	$ -15.63M	$ -17.55M	$ -145.17K	$ 923.23K	$ 675.07K
Total Liabilities	$ 6.14M	$ 7.62M	$ 1.99M	$ 2.00M	$ 833.53K
Stockholders' Equity	$ 21.21M	$ 21.63M	$ 211.66K	$ -954.84K	$ -735.38K
Cash Flow
Free Cash Flow	$ -9.56M	$ -5.55M	$ -1.83M	$ -658.49K	$ -496.66K
Operating Cash Flow	$ -8.78M	$ -5.25M	$ -1.83M	$ -657.30K	$ -495.80K
Investing Cash Flow	$ -656.15K	$ -14.62M	$ 0.00	$ -1.19K	$ -15.28K
Financing Cash Flow	$ 3.43M	$ 39.47M	$ 2.90M	$ 1.61M	$ 442.25K

Currency in USD

Sunshine Biopharma Earnings and Revenue History

Income Statement >

Sunshine Biopharma Debt to Assets

Balance Sheet >

Sunshine Biopharma Cash Flow

Cash Flow >

Sunshine Biopharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing